Allergy Treatment Market Size Growing at 5 8% CAGR, Set to Reach USD 36 2 Billion By 2032
virtual-strategy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virtual-strategy.com Daily Mail and Mail on Sunday newspapers.
EMA approves more sites for COVID-19 vaccines production
saudigazette.com.sa - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saudigazette.com.sa Daily Mail and Mail on Sunday newspapers.
Athens Times
The EMA approved 2 additional production Places for the Pfizer vaccine
The EMA Committee on Human Medicines (CHMP) announced that it has approved two additional production sites for Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer.
Published
The
EMA Committee on Human Medicines (CHMP) announced that it has approved two additional production sites for Comirnaty, the COVID-19 vaccine developed by
BioNTech and Pfizer.
Allergopharma GmbH & Co. KG. and the other in Stein, Switzerland and is managed by
Novartis Pharma.
The two production lines will carry out final product manufacturing steps at different stages of the process and are expected to support Comirnaty’s ongoing supply to the European Union.
El Comité de Medicamentos de Uso Humano de la Agencia Europea del Medicamento (EMA) ha aprobado otros dos centros de.